Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial
Finnian R. Mc Causland Brian Claggett; Marc A Pfeffer; Emmanuel de Almeida Burdmann; Kai-Uwe Eckardt; Andrew S Levey; John J. V McMurray; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert D Toto; Patrick Parfrey
American journal of nephrology v. 46, n. 6, p. 488-497, 2017Basel 2017
Localização: FM - Fac. Medicina (BCSEP 562 2017 )(Acessar)